Hosted by IDTechEx

Pharmaceuticals

Global Biotechnology Insights
Oct 2, 2017
Printed meds could reinvent pharmacies, drug research

Printed meds could reinvent pharmacies, drug research

A new process can print multiple medications onto a single dissolvable strip, microneedle patch or other surface.
Global Biotechnology Insights
Sep 22, 2017
One vaccine injection could carry many doses

One vaccine injection could carry many doses

Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered over an extended time period with just one injection.
Global Biotechnology Insights
Aug 11, 2017
Dozens of new genes that create T cell-resistant cancer discovered

Dozens of new genes that create T cell-resistant cancer discovered

To better understand why some cancers are resistant to immunotherapy, researchers collaborated on a large-scale CRISPR cancer study.
Global Biotechnology Insights
Jul 25, 2017
Upconverted light has a bright future

Upconverted light has a bright future

A professor's method to "upconvert" light could make solar cells more efficient and disease-targeting nanoparticles more effective.
Global Biotechnology Insights
Jul 14, 2017
Personalized cancer vaccine

Personalized cancer vaccine

A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients.
Global Biotechnology Insights
Jul 10, 2017
Strategic drug discovery collaboration

Strategic drug discovery collaboration

Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline.
Global Biotechnology Insights
Jun 16, 2017
Nanoparticles breathe new life into doxorubicin cancer treatment

Nanoparticles breathe new life into doxorubicin cancer treatment

Doxorubicin, originally daunorubicin, is the result of a simultaneous discovery event in the 1950's between researchers in France and Italy. The molecule, a well-known anti-cancer drug used for a variety of indications ranging from acute lymphocytic leukemia to breast cancer, was approved for use in the United States in 1974.
More IDTechEx Journals